Blood biomarkers with Parkinson's disease clusters and prognosis: the oxford discovery cohort

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression

(2018) Michael Lawton et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Precision medicine for disease modification in Parkinson disease

(2017) Alberto J. Espay et al.   Nature Reviews Neurology

Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer

(2017) Päivi Sirniö et al.   Scientific Reports

The ASA's Statement onp-Values: Context, Process, and Purpose

(2016) Ronald L. Wasserstein et al.   AMERICAN STATISTICIAN

Relation between plasma and brain lipids

(2016) Cheryl L. Wellington et al.   CURRENT OPINION IN LIPIDOLOGY

Molecular changes in the postmortem parkinsonian brain

(2016) Damien Toulorge et al.   JOURNAL OF NEUROCHEMISTRY

Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease

(2016) Naveed Malek et al.   MOVEMENT DISORDERS

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)

(2016) Caroline H. Williams-Gray et al.   MOVEMENT DISORDERS

Systematic Review of the Relationship between Vitamin D and Parkinson’s Disease

(2016) Lisanne M. Rimmelzwaan et al.   Journal of Parkinsons Disease

Evidence for the Importance of Vitamin D Status in Neurologic Conditions

(2015) Anusha K. Yeshokumar et al.   Current Treatment Options in Neurology

Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease

(2015) Elvira Valera et al.   Journal of Neuroinflammation

Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients

(2015) Christine R. Swanson et al.   MOVEMENT DISORDERS

Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort

(2015) Michael Lawton et al.   Journal of Parkinsons Disease

Mendelian randomization of serum urate and parkinson disease progression

(2014) Kelly Claire Simon et al.   ANNALS OF NEUROLOGY

Vitamin D from different sources is inversely associated with Parkinson disease

(2014) Liyong Wang et al.   MOVEMENT DISORDERS

Microglial priming in neurodegenerative disease

(2014) V. Hugh Perry et al.   Nature Reviews Neurology

Vitamin D receptor polymorphisms and susceptibility to Parkinson’s disease and Alzheimer’s disease: a meta-analysis

(2014) Young Ho Lee et al.   NEUROLOGICAL SCIENCES

Association between vitamin D receptor gene polymorphisms and susceptibility to Parkinson's disease: A meta-analysis

(2014) Zi-Teng Zhang et al.   NEUROSCIENCE LETTERS

Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease

(2014) Michael A. Schwarzschild et al.   JAMA Neurology

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

(2013) Judy K. Qiang et al.   ANNALS OF NEUROLOGY

A systematic review of biomarkers for disease progression in Parkinson’s disease

(2013) David JM McGhee et al.   BMC Neurology

Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study

(2013) Debbie A Lawlor et al.   LANCET

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study

(2013) H. Ding et al.   NEUROLOGY

Microglia, Amyloid and Glucose Metabolism in Parkinson’s Disease with and without Dementia

(2013) Paul Edison et al.   NEUROPSYCHOPHARMACOLOGY

The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort

(2013) Konrad Szewczyk-Krolikowski et al.   PARKINSONISM & RELATED DISORDERS

Blood-based biomarkers for Parkinson's disease

(2013) Lama M. Chahine et al.   PARKINSONISM & RELATED DISORDERS

Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis

(2013) Liang Shen et al.   BMJ Open

Vitamin D Receptor Gene as a Candidate Gene for Parkinson Disease

(2011) Megan W. Butler et al.   ANNALS OF HUMAN GENETICS

Serological Profiles of Urate, Paraoxonase-1, Ferritin and Lipid in Parkinson’s Disease: Changes Linked to Disease Progression

(2011) Ken Ikeda et al.   Neurodegenerative Diseases

The Risk of Parkinson Disease Associated with Urate in a Community-Based Cohort of Older Adults

(2011) S. Jain et al.   NEUROEPIDEMIOLOGY

Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease

(2010) Terry L. Lewis et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study

(2009) H. Chen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease

(2009) Alberto Ascherio   ARCHIVES OF NEUROLOGY

Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease

(2008) Michael A. Schwarzschild   ARCHIVES OF NEUROLOGY